About Lonza　

Lonza is one of the world’s leading and most trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create productsthat support safer and healthier living and that enhance the overall quality of life.

Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 10,000 employees worldwide. The company generated sales of about CHF 3.6 billion in 2013 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges. Further information can be found at www.lonza.com.

關于龍沙

龍沙是制藥、生物技術與特殊成分等市場上全球領先及最值得信賴的供應商之一。我們運用科學技術創(chuàng)造產(chǎn)品，促進更安全、更健康的生活，同時提高整體生活質量。

龍沙不僅是定制生產(chǎn)商和定制開發(fā)商，同時致力為客戶提供服務與產(chǎn)品，從活性醫(yī)藥成分、干細胞療法到飲用水殺菌劑，從維生素B化合物、個人護理有機成分到農用化學品，從工業(yè)防腐劑到可抗擊有害病毒、細菌及其他病原體的微生物控制解決方案。

1897年，龍沙創(chuàng)建于瑞士的阿爾卑斯山脈地區(qū)，迄今已發(fā)展為一家享譽盛名的跨國企業(yè)，在全球建有40多個核心生產(chǎn)基地和研發(fā)中心并擁有約10000名員工。2013年，龍沙的銷售額約為36億瑞士法郎，公司以市場為導向的兩大領域進行設置：制藥與生物技術、特殊成分。龍沙的股票在瑞士和新加坡證券交易所上市交易。欲了解更多，請訪問www.lonza.com.